Advertisement

Organisation › Details
Johnson & Johnson (JnJ) (Group)
Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 250 Johnson & Johnson operating companies employ approximately 121,000 men and women in 57 countries and sell products throughout the world. *
![]() |
Start | 1888-01-01 established? |
![]() |
Industry | pharmaceutical |
Industry 2 | diagnostics (medical/biological) | |
Street | One Johnson & Johnson Plaza | |
City | 08933 New Brunswick, NJ | |
Address record changed: 2008-12-07 | ||
Basic data | Employees | J: more than 100,0 (2017-01-26) |
Currency | USD | |
Annual sales | 61,095,000,000 (sales, consolidated (2007) 2007-12-31) | |
Profit | 10,576,000,000 (2007-12-31) | |
Cash | 16,055,000,000 (2005-12-31) | |
* Document for �About Section�: | ||
Record changed: 2019-08-01 |
Advertisement
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
More documents for Johnson & Johnson (JnJ) (Group)
- [1] MorphoSys AG. (9/16/19). "Press Release: MorphoSys's Licensee Janssen Submits Biologics License Application to U.S. FDA of Tremfya (Guselkumab) for Treatment of Adults with Active Psoriatic Arthritis". Planegg....
- [2] MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY....
- [3] Alligator Bioscience AB. (7/31/19). "Press Release: Alligator Bioscience Regains Global Rights from Janssen to CD40 Agonistic Antibody, ADC-1013 (JNJ-64457107)". Lund....
- [4] Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey....
- [5] Genmab A/S. (6/11/19). "Press Release: Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody-CD38". Copenhagen....
- [6] Owlstone Medical Ltd.. (5/20/19). "Press Release: Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension". Cambridge....
- [7] MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY....
- [8] Iktos. (4/29/19). "Press Release: Iktos Announces Research Collaboration with Janssen to Utilize Iktos’ Artificial Intelligence Technology to Increase Speed & Efficiency of Small Molecule Drug Discovery". Paris....
- [9] MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY....
- [10] Argenx SE. (2/28/19). "Press Release: Argenx Reports Fourth Quarter Business Update and Full Year 2018 Financial Results". Breda & Ghent....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top